Vericiguat

Vericiguat API (CAS No: 1350653-20-1) is carefully produced at Amber Lifesciences Pvt. Ltd. in GMP-certified and ISO 9001:2015 compliant manufacturing facilities, ensuring excellent purity, consistency, and alignment with global regulatory requirements. Each batch is accompanied by a detailed Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), meeting the standards of USP/EP pharmacopeial specifications.

Vericiguat is a soluble guanylate cyclase (sGC) stimulator indicated for reducing the risk of cardiovascular death and heart failure hospitalization in patients with symptomatic chronic heart failure. It enhances the nitric oxide signaling pathway, promoting vasodilation and improved cardiac function. Our API undergoes stringent quality control procedures and validated production processes to ensure high reliability and efficacy in pharmaceutical applications.

Amber Lifesciences partners with pharmaceutical companies, manufacturers, shippers,  formulation developers, exporters, and distributors across Asia, Europe, the Middle East, and LATAM regions, providing dependable supply chains, expert technical support, and comprehensive regulatory documentation to streamline product registration and facilitate timely market access.

Storage & Transportation

Classified as non-Dangerous Goods. Store at controlled room temperature (20°C to 25°C / 68°F to 77°F), protected from light, moisture, and excessive heat. Follow standard pharmaceutical handling and storage protocols.

 

CAS No.:
1350653-20-1
Synonym:
Verquvo MK-1242
Mol. formula:
C19H16F2N8O2
Mol. Weight:
426.4 g/mol

Active Pharmaceutical Ingredient (API) – Not for Direct Human or Veterinary Use.

Connect with Amber for Your API Solutions and Innovations!

Your API solutions are just a connection away – reach out to us now!

4 + 9 =